For the month ended 31 March 2026, Sino-Life Group Limited reported no change in its share structure. Issued ordinary shares remained at 94.50 million, with zero treasury shares outstanding.

Authorised share capital stayed at 1.00 billion ordinary shares with a par value of HKD 1.00 each, leaving total authorised capital unchanged at HKD 1.00 billion.

The company reaffirmed that the public float exceeded the 25 % threshold required under GEM Rule 17.37D(1).

Equity incentive exposure is modest: 1.85 million share options were outstanding, representing a potential dilution of about 1.96 % of issued shares if fully exercised; no options were exercised during the month.

Convertibles on the balance sheet consist of HKD 18.16 million (USD equivalent not provided) in convertible bonds, convertible at HKD 1.26 per share. Full conversion would add up to 18.16 million new shares—an incremental 19.22 % relative to the current share base.

No warrants, other share issuance agreements, repurchases, or treasury share movements were recorded in March 2026. All necessary regulatory confirmations were filed by the company secretary, indicating compliance with Hong Kong listing requirements.